We would love to hear your thoughts about our site and services, please take our survey here.
It happens because it's just a calculation used.
Anything above the mid point of the spread is presented as a Buy, anything below is presented as a Sell, anything bang on the mid point is neutral (and often not included in summary of buys/sells).
I'd be very surprised, given the price, if the 500k wasn't a buy.
3.75 called out by Zak
https://x.com/share_talk/status/1728151029936525770?s=46&t=Cg5DkJBWNFHymDApBAKX6Q
Https://www.voxmarkets.co.uk/articles/5-bargain-shares--d287c5c/
5 mins 15 seconds in
Ha.. looks like you used the wrong account to post 'Lazy_dilettante', or is it 'Exoptimist'?
It must be confusing having so many accounts to remember who you are.
Hey bumbag, I'm not sure you're looking at the right RNS;
"The Company took swift action to improve operational efficiency and appointed Chartwell Consulting, a global specialist in delivering operational performance improvements in healthcare manufacturing, to work with us to deliver improvements in our production processes and establishing new preventative procedures. We have already seen a very material increase in yield and the improvements will help meet the demand for our food sensitivity tests, which continues to be strong."
"Chartwell Consulting, a global specialist in delivering operational performance improvements in healthcare manufacturing, was appointed in February and has been working with the team to deliver additional production yield improvements whilst reducing the FoodPrint® slide manufacturing cycle time. This has had a positive impact already in terms of the aforementioned improvements."
"we have taken swift action to bring in consultants to oversee a number of process improvements and are confident the actions being taken will deliver a material improvement in yield in the near term. Embedding key lessons learned from this is part of laying a brand-new foundation for a business that is emerging from a group structure and learning to stand on its own two feet."
" the Board appointed Chartwell Consulting to undertake a review of micro-array production and to recommend and help implement an improvement plan, with the aim of returning yields to the 2020 high or better and to significantly reduce manufacturing and quality control lead times. These objectives have largely been achieved, with a number of all-time high yields achieved in recent weeks,"
As are, seemingly, the 100000+ buyers.
From the DVTRG AGM Q&A also;
----------
Q25: Any updates you can give regarding partnerships with Microsaic and Abingdon Health
Microsaic is such an under-rated turnaround project. That we cooperate on upgrading equipment in Modern Water and take their PFAS technology and roll it out through the Modern Water distributor channels makes it work so well. Abingdon Health is also a development that will offer multiple revenue streams as extensions in the field for Modern Water monitoring and is a perfect marketing tool to quickly show potential clients that they have a problem, even before installation. Once the client is shown the problem, it becomes so much easier to offer a long term monitoring service and large equipment installation. This is as useful for legionella in stagnant water in hotels and on ships, as it is for acrylamides in manufacturing production of food. We look forward to rolling a range of LFT's out in the few months and years ahead as we build the fast-track offering of LFT's through the group
---------
I'm all for it. But by golly Caley, you're using all the words up. Give others a chance.
Happy Friday everyone.
It's also stated, before now, that the free to use tests, provided by NHS, are not eligible for use/confirmation when travelling.
https://www.gov.uk/guidance/coronavirus-covid-19-testing-for-people-travelling-to-england#type-of-test
"NHS tests cannot be used for the purpose of pre-departure testing before travel to England.
You cannot take an NHS test abroad with you to use on yourself before you return."
Given that FlowFlex is the current NHS provided test, there needs to be alternative UK approved self-test tests available to support the travel sector. Perhaps there's a way (QR Code/batch numbers) to differentiate the NHS Flowflex tests from Private use Flowlfex. Who knows.
Quaytec - They're not shutdown though.
They are manufacturing, on ODX owned kit, the Visitect Antigen, CD4, and ABC-19 tests.
They are far from twiddling their thumbs.
EU Home Use Approval is expected any time now, and will be the catalyst to a total sentiment change on this board, and more importantly to the SP.
Harvey, you're right in it being transport.
It's 'International logistics' firm http://www.sovcargo.co.uk
Thank GTC.
I think the Sovereign photo is for a transport company;
http://www.sovcargo.co.uk
Hope it doesn't hit too hard RegulatorUK.
You prompted me to take a couple, as I have a cold at present. Orient Gene and FlowFlex, thankfully both negative.
Get well soon
Surprisingly not Regulator. I've not seen Twacther post for a couple of days. Seems he's morphed into HarveyF.
But plenty of others also providing their thoughtful insight.
Hope all is well with your good self.
From the AGM Q&A;
"The 2021 accounts were signed off in July 2021 on a going concern basis, which involves a review of the Company’s cash flow forecasts for at least the next 12 months, including a consideration of a number of downside sensitivities. The Board’s conclusion was that the accounts could be signed off on the going concern basis and the auditors, EY concurred."
"At least" 12 months run on current cash/income, before considering expected Covid revenues.
"The Board has no current plans to raise further funds from investors as the anticipated sales demand is expected to generate sufficient cash to enable the Company to manage its cash flow, without the need for further external funding."
It's a shame you do though Gary
That's a lot to spend time typing out, Twatcher, when you can just look at the Q&As from the investor presentation just a few weeks ago. Quite a fitting question for this board, I feel.
Q116: It was stated previously that on social media platforms those who engaged in market manipulation practices would be dealt with. Since that message it has only gotten worse, with more and more accounts appearing quoting "placings" incoming etc. What has been done about this and what will be done going forward?
"It is impossible for us to police social media – people will use it to spread false information and to criticize us by there is nothing that we can do as a company. We have made our position clear on our need for cash – we have a strong cash position and do not require an additional Placing to raise money for working capital."
Just 15 working days, since that RNS. It must be close.